{"id":"https://openalex.org/W2131446563","doi":"https://doi.org/10.2174/1573399810666141224121927","title":"Addressing Unmet Medical Needs in Type 2 Diabetes: A Narrative Review of Drugs under Development","display_name":"Addressing Unmet Medical Needs in Type 2 Diabetes: A Narrative Review of Drugs under Development","alternate_titles":[],"publication_year":2015,"publication_date":"2015-01-22","ids":{"openalex":"https://openalex.org/W2131446563","doi":"https://doi.org/10.2174/1573399810666141224121927","mag":"2131446563","pmid":"https://pubmed.ncbi.nlm.nih.gov/25537454","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4428473"},"language":"en","primary_location":{"id":"doi:10.2174/1573399810666141224121927","doi":"https://doi.org/10.2174/1573399810666141224121927","is_oa":true,"landing_page_url":"https://doi.org/10.2174/1573399810666141224121927","pdf_url":"http://www.eurekaselect.com/article/64142","source":{"id":"https://openalex.org/S204739293","display_name":"Current Diabetes Reviews","issn_l":"1573-3998","issn":["1573-3998","1875-6417"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Diabetes Reviews","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2131446563"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.eurekaselect.com/article/64142","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111781978","display_name":"Friedrich Mittermayer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28927889","display_name":"IQVIA (United Kingdom)","ror":"https://ror.org/040g76k92","country_code":"GB","type":"company","lineage":["https://openalex.org/I28927889","https://openalex.org/I4210108991"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Friedrich Mittermayer","raw_affiliation_strings":["Quintiles GmbH, Stella- Klein-Low Weg 15, Rund 4, Haus B, OG 4, 1020 Vienna, Austria.,Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quintiles GmbH, Stella- Klein-Low Weg 15, Rund 4, Haus B, OG 4, 1020 Vienna, Austria.,Austria","institution_ids":["https://openalex.org/I28927889"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000355875","display_name":"Erica J. Caveney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Erica Caveney","raw_affiliation_strings":["Diabetes Center of Excellence, Quintiles, Dur-ham, NC, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes Center of Excellence, Quintiles, Dur-ham, NC, USA;","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039120621","display_name":"Cl\u00e1udia de F\u00e1tima OLIVEIRA","orcid":"https://orcid.org/0000-0002-3130-4061","observed_orcids":["https://orcid.org/0000-0002-3130-4061"]},"institutions":[{"id":"https://openalex.org/I28927889","display_name":"IQVIA (United Kingdom)","ror":"https://ror.org/040g76k92","country_code":"GB","type":"company","lineage":["https://openalex.org/I28927889","https://openalex.org/I4210108991"]},{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Claudia De Oliveira","raw_affiliation_strings":["Cardiovascular and Metabolic Diseases, Quintiles, Durham, NC, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Diseases, Quintiles, Durham, NC, USA;","institution_ids":["https://openalex.org/I28927889","https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039780178","display_name":"Loukas Gourgiotis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28927889","display_name":"IQVIA (United Kingdom)","ror":"https://ror.org/040g76k92","country_code":"GB","type":"company","lineage":["https://openalex.org/I28927889","https://openalex.org/I4210108991"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Loukas Gourgiotis","raw_affiliation_strings":["Cardiovascular and Metabolic Diseases, Quintiles, Reading, UK;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Diseases, Quintiles, Reading, UK;","institution_ids":["https://openalex.org/I28927889"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013030949","display_name":"Mala Puri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28927889","display_name":"IQVIA (United Kingdom)","ror":"https://ror.org/040g76k92","country_code":"GB","type":"company","lineage":["https://openalex.org/I28927889","https://openalex.org/I4210108991"]},{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["GB","US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Mala Puri","raw_affiliation_strings":["Cardiovascular and Metabolic Diseases, Quintiles, Durham, NC, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Diseases, Quintiles, Durham, NC, USA;","institution_ids":["https://openalex.org/I28927889","https://openalex.org/I4210108991"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Li-Jung Tai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108991","display_name":"IQVIA (United States)","ror":"https://ror.org/01mk44223","country_code":"US","type":"company","lineage":["https://openalex.org/I4210108991"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Li-Jung Tai","raw_affiliation_strings":["Cardiovascular and Metabolic Diseases, Quintiles, San Diego, CA, USA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiovascular and Metabolic Diseases, Quintiles, San Diego, CA, USA;","institution_ids":["https://openalex.org/I4210108991"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112767709","display_name":"J. Rick Turner","orcid":"https://orcid.org/0000-0001-5971-2289","observed_orcids":["https://orcid.org/0000-0001-5971-2289"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J. Rick Turner","raw_affiliation_strings":["Quintiles GmbH, Stella- Klein-Low Weg 15, Rund 4, Haus B, OG 4, 1020 Vienna, Austria. friedrich.mittermayer@quintiles.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quintiles GmbH, Stella- Klein-Low Weg 15, Rund 4, Haus B, OG 4, 1020 Vienna, Austria. friedrich.mittermayer@quintiles.com","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5111781978"],"corresponding_institution_ids":["https://openalex.org/I28927889"],"apc_list":null,"apc_paid":null,"fwci":1.0857,"has_fulltext":true,"cited_by_count":52,"citation_normalized_percentile":{"value":0.71428571,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"11","issue":"1","first_page":"17","last_page":"31"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/unmet-medical-needs","display_name":"unmet medical needs","score":0.847000002861023},{"id":"https://openalex.org/keywords/antidiabetic-drugs","display_name":"antidiabetic drugs","score":0.7710000276565552},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.9350000023841858},{"id":"https://openalex.org/keywords/ppar-agonists","display_name":"PPAR agonists","score":0.9399999976158142},{"id":"https://openalex.org/keywords/glucokinase-activators","display_name":"glucokinase activators","score":0.9929999709129333},{"id":"https://openalex.org/keywords/glucagon-receptor-antagonists","display_name":"glucagon receptor antagonists","score":0.9940000176429749},{"id":"https://openalex.org/keywords/anti-inflammatory-agents","display_name":"anti-inflammatory agents","score":0.8759999871253967},{"id":"https://openalex.org/keywords/g-protein-coupled-receptor-agonists","display_name":"G protein-coupled receptor agonists","score":0.9769999980926514},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.7459999918937683},{"id":"https://openalex.org/keywords/11beta-hsd1-inhibitors","display_name":"11\u03b2-HSD1 inhibitors","score":0.9399999976158142},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.8579999804496765},{"id":"https://openalex.org/keywords/oral-insulin","display_name":"oral insulin","score":0.9240000247955322}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8456703424453735},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7011492252349854},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5633007884025574},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5451301336288452},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5301343202590942},{"id":"https://openalex.org/C2776307423","wikidata":"https://www.wikidata.org/wiki/Q425027","display_name":"Glimepiride","level":4,"score":0.5146454572677612},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.49342241883277893},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3521152138710022},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.22647741436958313},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08070671558380127}],"mesh":[{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015195","descriptor_name":"Drug Design","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020380","descriptor_name":"Needs Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047492","descriptor_name":"Peroxisome Proliferator-Activated Receptors","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.2174/1573399810666141224121927","doi":"https://doi.org/10.2174/1573399810666141224121927","is_oa":true,"landing_page_url":"https://doi.org/10.2174/1573399810666141224121927","pdf_url":"http://www.eurekaselect.com/article/64142","source":{"id":"https://openalex.org/S204739293","display_name":"Current Diabetes Reviews","issn_l":"1573-3998","issn":["1573-3998","1875-6417"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Diabetes Reviews","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:4428473","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC4428473/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Curr Diabetes Rev","raw_type":"Text"},{"id":"pmid:25537454","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25537454","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current diabetes reviews","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.2174/1573399810666141224121927","doi":"https://doi.org/10.2174/1573399810666141224121927","is_oa":true,"landing_page_url":"https://doi.org/10.2174/1573399810666141224121927","pdf_url":"http://www.eurekaselect.com/article/64142","source":{"id":"https://openalex.org/S204739293","display_name":"Current Diabetes Reviews","issn_l":"1573-3998","issn":["1573-3998","1875-6417"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Diabetes Reviews","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2131446563.pdf","grobid_xml":"https://content.openalex.org/works/W2131446563.grobid-xml"},"referenced_works_count":131,"referenced_works":["https://openalex.org/W33533804","https://openalex.org/W102407095","https://openalex.org/W1518589347","https://openalex.org/W1546680426","https://openalex.org/W1565242819","https://openalex.org/W1590943075","https://openalex.org/W1602648506","https://openalex.org/W1877152454","https://openalex.org/W1964607604","https://openalex.org/W1964925331","https://openalex.org/W1965576057","https://openalex.org/W1966710530","https://openalex.org/W1968402461","https://openalex.org/W1970743385","https://openalex.org/W1970905724","https://openalex.org/W1972051717","https://openalex.org/W1972258960","https://openalex.org/W1974591474","https://openalex.org/W1975588287","https://openalex.org/W1975820359","https://openalex.org/W1977484873","https://openalex.org/W1979543957","https://openalex.org/W1984003917","https://openalex.org/W1984089538","https://openalex.org/W1986038576","https://openalex.org/W1987802058","https://openalex.org/W1994121001","https://openalex.org/W1999174748","https://openalex.org/W2003946536","https://openalex.org/W2009237205","https://openalex.org/W2010139988","https://openalex.org/W2013481385","https://openalex.org/W2014660011","https://openalex.org/W2016025876","https://openalex.org/W2017549808","https://openalex.org/W2022227132","https://openalex.org/W2023615726","https://openalex.org/W2024941488","https://openalex.org/W2025436379","https://openalex.org/W2027862526","https://openalex.org/W2029145065","https://openalex.org/W2033726284","https://openalex.org/W2036141586","https://openalex.org/W2037888379","https://openalex.org/W2041687156","https://openalex.org/W2042914433","https://openalex.org/W2043759658","https://openalex.org/W2046311978","https://openalex.org/W2046912474","https://openalex.org/W2053581007","https://openalex.org/W2055176295","https://openalex.org/W2058969403","https://openalex.org/W2059158127","https://openalex.org/W2061827267","https://openalex.org/W2062842771","https://openalex.org/W2065886331","https://openalex.org/W2066841620","https://openalex.org/W2070291568","https://openalex.org/W2070521312","https://openalex.org/W2070841384","https://openalex.org/W2071151531","https://openalex.org/W2074572192","https://openalex.org/W2078915908","https://openalex.org/W2082504721","https://openalex.org/W2085993091","https://openalex.org/W2086355314","https://openalex.org/W2087036494","https://openalex.org/W2087701253","https://openalex.org/W2091685843","https://openalex.org/W2091977092","https://openalex.org/W2092020543","https://openalex.org/W2093587125","https://openalex.org/W2095364171","https://openalex.org/W2095682936","https://openalex.org/W2096418655","https://openalex.org/W2103420601","https://openalex.org/W2105900654","https://openalex.org/W2108030886","https://openalex.org/W2109728760","https://openalex.org/W2111876001","https://openalex.org/W2121367813","https://openalex.org/W2123578975","https://openalex.org/W2127167047","https://openalex.org/W2129010395","https://openalex.org/W2129128065","https://openalex.org/W2135978651","https://openalex.org/W2142370026","https://openalex.org/W2143044822","https://openalex.org/W2144278955","https://openalex.org/W2150107812","https://openalex.org/W2150327210","https://openalex.org/W2150367899","https://openalex.org/W2151729372","https://openalex.org/W2153041556","https://openalex.org/W2153570040","https://openalex.org/W2154279165","https://openalex.org/W2154497567","https://openalex.org/W2156597872","https://openalex.org/W2156964194","https://openalex.org/W2157627492","https://openalex.org/W2157748967","https://openalex.org/W2157835722","https://openalex.org/W2161948968","https://openalex.org/W2163109807","https://openalex.org/W2163448046","https://openalex.org/W2164854327","https://openalex.org/W2165779664","https://openalex.org/W2167727277","https://openalex.org/W2167907853","https://openalex.org/W2168577834","https://openalex.org/W2168843846","https://openalex.org/W2169848635","https://openalex.org/W2170695489","https://openalex.org/W2172193326","https://openalex.org/W2302447233","https://openalex.org/W2312946897","https://openalex.org/W2331260641","https://openalex.org/W2337454357","https://openalex.org/W2343801153","https://openalex.org/W2465450337","https://openalex.org/W2504725357","https://openalex.org/W2789732774","https://openalex.org/W3122152400","https://openalex.org/W4229629337","https://openalex.org/W4230892627","https://openalex.org/W4242364069","https://openalex.org/W4251853658","https://openalex.org/W6643192713","https://openalex.org/W6682010804","https://openalex.org/W6682061514","https://openalex.org/W7047394103"],"related_works":["https://openalex.org/W2621868171","https://openalex.org/W2357495174","https://openalex.org/W2028825404","https://openalex.org/W2044064793","https://openalex.org/W2613715913","https://openalex.org/W2368868004","https://openalex.org/W3047463268","https://openalex.org/W2068350553","https://openalex.org/W3041984460","https://openalex.org/W4205946014"],"abstract_inverted_index":{"The":[0,95],"global":[1],"burden":[2],"of":[3,13,19,24,44,64,68,72],"type":[4],"2":[5],"diabetes":[6],"is":[7],"increasing":[8],"worldwide,":[9],"and":[10,30,79,128,132],"successful":[11],"treatment":[12],"this":[14,69,93],"disease":[15],"needs":[16],"constant":[17],"provision":[18],"new":[20,32,62,96],"drugs.":[21],"Twelve":[22],"classes":[23,98],"antidiabetic":[25],"drugs":[26,33,60],"are":[27,34,75],"currently":[28],"available,":[29],"many":[31],"under":[35],"clinical":[36],"development.":[37],"These":[38],"include":[39,59,100],"compounds":[40,74],"with":[41,61,81],"known":[42],"mechanisms":[43,63],"action":[45],"but":[46],"unique":[47],"properties,":[48],"such":[49],"as":[50],"once-weekly":[51],"DPP4":[52],"inhibitors":[53],"or":[54],"oral":[55],"insulin.":[56],"They":[57],"also":[58],"action,":[65],"the":[66],"focus":[67],"review.":[70],"Most":[71],"these":[73],"in":[76],"Phase":[77,90],"1":[78],"2,":[80],"only":[82],"a":[83],"small":[84],"number":[85],"having":[86],"made":[87],"it":[88],"to":[89],"3":[91],"at":[92],"time.":[94],"drug":[97],"described":[99],"PPAR":[101],"agonists/modulators,":[102],"glucokinase":[103],"activators,":[104],"glucagon":[105],"receptor":[106,112],"antagonists,":[107],"anti-inflammatory":[108],"compounds,":[109],"G-protein":[110],"coupled":[111],"agonists,":[113],"gastrointestinal":[114],"peptide":[115],"agonists":[116],"other":[117],"than":[118],"GLP-1,":[119],"apical":[120],"sodium-dependent":[121],"bile":[122],"acid":[123],"transporter":[124],"(ASBT)":[125],"inhibitors,":[126,131],"SGLT1":[127],"dual":[129],"SGLT1/SGLT2":[130],"11beta-":[133],"HSD1":[134],"inhibitors.":[135]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2131446563","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
